Executive Officer at SME

Moon Kil Woong is currently a VP at a SME. Previously he was a tech stock consultant, VP of Research at ING, and sell side Director at Crédit Agricole Indosuez. Moon Kil Woong has a Masters in Public Administration from SJSU.

He contributes to both TalkMarkets and Seeking ... more

ALL CONTRIBUTIONS

E HIV Cure Challenger CytoDyn Takes On Gilead Sciences
CytoDyn believes they have a cure for HIV that will work on a subpopulation of patients with cancer.
Read
E My Take On Recessionary Indicators
Despite the regularity of economic downturns and the existence of business cycles in a free market economy it is quite obvious that recession calling remains an art more than a science with the scientists being wrong consistently.
Read

Comments

Latest Comments
Tech Is In La-La Land
2 days ago

Indeed you are right that the online shopping market has done well as evidenced by Amazon and Google. As for all of tech, we will see if tech hardware can push through their inventory build and reorder strongly or not.

In this article: QQQ
HIV Cure Challenger CytoDyn Takes On Gilead Sciences
2 days ago

Here is more information if you are interested in this topic. It was released after the market closed furthering the case of its ability to effectively fight HIV and possibly be a cure. www.cytodyn.com/.../cytodyns-leronlimab-prevents-transmission-of-shiv-in

In this article: CYDY, GILD
HIV Cure Challenger CytoDyn Takes On Gilead Sciences
2 days ago

Thanks for your question. As you may or may not know, Cytodyn has been working on AIDS treatments and have several completed phase 1 and 2 studies with the CDC. Here is a look if you wish to look further into it.

www.contagionlive.com/.../leronlimab-pro-140-advances-as-an-hiv-combination-therapy-candidate

aidsinfo.nih.gov/drugs/423/leronlimab/0/patient

You are correct that the drug approvals process takes time, however, Cytodyn is already well on its way and I feel that the story is a good one to make at this point of time given it's potential to redefine AIDS treatment and also possibly eliminate AIDS in patients. There is evidence that this may be occurring already during the approved studies although the current studies were not designed to test this incredible turn of events exhaustively nor determine treatment levels, duration, and necessary criteria for this to happen for patients.

Regarding Covid, people are rushing to the gates with solutions for Covid, however, Cytodyn is already well on its way not to get started with a submission for human trials, but has already subscribed and is treating patients under phase II. We are waiting for the FDA to give a finalized date for the official findings on the shorter period test.

Thus now is the time to be looking at Cytodyn if you are interested in it and their drug before concept becomes official reality. Frankly, I am surprised that I am one of the fees off of other things.

As mentioned before, I was interested in Cytodyn due to their Cancer AIDS treatments before Covid topped the list of why people are interested in this company. I think it's a good time to tell this story even if it gets overshadowed by other things. For me it's all about the science. The stock price will follow regardless of how traders spin things short term.

In this article: CYDY, GILD
HIV Cure Challenger CytoDyn Takes On Gilead Sciences
2 days ago

This is a very good question about publicity. The networks don’t like to take on companies that have a bulletin board designation. Even though this is one of the most actively traded stock in OTC there is still that media stigma that seems to temper the level of reporting. In light of that backdrop, what we have here is a theory to cure HIV. It hasn’t been demonstrated yet or been dosed in a person. Right now it’s in the incubator stage but should get traction if the FDA approves dosing or the company announces the initiation of the trial. They also plan to ask for an emergency IND. So to answer your question its too early and the timeline will be established when the trial design is revealed.

In this article: CYDY, GILD
Gratuitously Impatient (For A) Rebound
2 days ago

Another good article. We are behind China in recovery because we have had an inadequate national response that is having us have more cases now than ever before. Even if we reopen business, the economy will not recover unless the infections stop or we find a cure or a diagnosis that will keep this disease from being deadly. Fortunately, there are several companies working on diagnosis and cures.

Tech Is In La-La Land
2 days ago

Tech has been less affected from Covid and semis have done well as people chose to upgrade their home systems during Covid. That said, it may be a little overdone depending on how things pan out. A lot of the channel built back up stock and we'll see how long it takes for them to push it out in the next few months.

In this article: QQQ
Bitcoin Chart Analysis: This Is The Key To An Epic Move
3 days ago

Bitcoin despite what people think does not move based on dollar or any other type of depreciation. It moves based upon the dynamic of its industry and news about itself. It is unfortunate that there are so many crypto currencies because this acts as a devaluation in the whole market which takes away money going to the existing crypto currencies. This sort of "devaluation" far exceeds the devaluation the US dollar is going through.

Hopefully, the new coin issues are slowing down. This I think is reflected in bitcoin's price stabilizing.

In this article: BITCOMP
US: Business Getting Back On Track
3 days ago

I think the numbers show some level of confidence as businesses restock to some degree. We will see if sell thought occurs as total incomes have dropped in the US. The stimulus hardly makes up for it.

"Panic-Driven Hoarding Of Bank Notes:" People Aren't Abandoning Cash During The Pandemic, They're Socking It Away
4 days ago

Agreed. Also digital currency like bitcoin has a terrible way of using inordinate amounts of memory and if you lose your password you have in essence lost your ability to use it which is not a very good solution for users.

What Will Push Stocks Higher?
4 days ago

CDCY is a treatment to prevent it from causing your body from over reacting to Covid although it may inhibit its growth and spread as well. So as we wait for newfangled attempts to make a vaccine without negative effects hopefully drugs like this will pan out making Covid less deadly.

Progress in little steps is often how we arise with a solution.

1 to 10 of 1979 comments
1 2 3 ... 198

STOCKS I FOLLOW

GOOG Alphabet Inc. (Google)
SKM SK Telecom Co. Ltd.

TWEETS

PERSONAL BLOG

Latest Posts

Work Experience

Education

San Jose State University
MPA
Public Administration

Publications